SECOND AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • April 14th, 2022 • BeyondSpring Inc. • Pharmaceutical preparations
Contract Type FiledApril 14th, 2022 Company IndustryThis Second Amendment to Employment Agreement (this “Second Amendment”) is entered into on January 11, 2022 (the “Effective Date”) by and between BeyondSpring Pharmaceuticals, Inc. (“Company”) and Dr. Lan Huang (“Employee”) (collectively, the “Parties”).
SECOND AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • April 14th, 2022 • BeyondSpring Inc. • Pharmaceutical preparations
Contract Type FiledApril 14th, 2022 Company IndustryThis Second Amendment to Employment Agreement (this "Second Amendment") is entered into on January 11, 2022 (the "Effective Date") by and between BeyondSpring Pharmaceuticals, Inc. ("Company") and Dr. Ramon Mohanlal ("Employee") (collectively, the "Parties").
Thirteenth Amendment to Consulting AgreementConsulting Agreement • April 14th, 2022 • BeyondSpring Inc. • Pharmaceutical preparations • California
Contract Type FiledApril 14th, 2022 Company Industry JurisdictionThis Thirteenth Amendment ("Amendment") to Consulting Agreement is effective as of January 01, 2022 (the “Effective Date”) and is entered into by and between GKOL, Inc., a California corporation, with an office at 210 Montalvo Road, Redwood City, CA 94062 (“GKOL”), and BeyondSpring Pharmaceuticals, Inc., a Delaware Corporation, with an office at 28 Liberty Street, 39th Floor, New York, New York 10005 USA ("BeyondSpring").
THIRD AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • April 14th, 2022 • BeyondSpring Inc. • Pharmaceutical preparations
Contract Type FiledApril 14th, 2022 Company IndustryThis Third Amendment to Employment Agreement (this “Amendment”), dated this 12th day of October, 2021 (the "Effective Date"), is entered into by and between BeyondSpring Pharmaceuticals, Inc. (the “Company”) and Mr. Richard Daly ( “Employee”).
Separation and Release AgreementSeparation and Release Agreement • April 14th, 2022 • BeyondSpring Inc. • Pharmaceutical preparations
Contract Type FiledApril 14th, 2022 Company IndustryThis Separation and Release of Claims Agreement ("Agreement") is entered into by and between BeyondSpring Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at 28 Liberty Street, New York, NY 10005 (the "Employer"), and Richard Daly, an Illinois resident working for Employer in New York (the "Employee") (collectively the “Parties” and each a “Party”) effective as of the date set forth below.
FIRST AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • April 14th, 2022 • BeyondSpring Inc. • Pharmaceutical preparations
Contract Type FiledApril 14th, 2022 Company IndustryThis First Amendment to Employment Agreement (this “Amendment”) is entered into on January 11, 2022 (the “Effective Date”) by and between BeyondSpring Pharmaceuticals, Inc. (“Company”) and Elizabeth Czerepak (“Employee”) (collectively, the “Parties”).
CONSULTING AGREEMENTConsulting Agreement • April 14th, 2022 • BeyondSpring Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledApril 14th, 2022 Company Industry JurisdictionTHIS CONSULTING AGREEMENT (“Agreement”) dated Nov. 6, 2021 (the “Effective Date”) is made between BeyondSpring Pharmaceuticals, Inc., a corporation organized under the laws of Delaware, having its principal place of business at 28 Liberty Street, 39th Floor, New York, NY 10005 (the “Company”) and Brendan Delaney, having a principal place of business at 475 Park Ave. Leonia, New Jersey 07605 (“Consultant”), for the purpose of setting forth the exclusive terms and conditions by which the Company desires to acquire Consultant’s services on a temporary basis.